(Q42110040)

16 October 2017

Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase (English)

1 reference

16 October 2017

1 reference

Hidehiro Sangawa

1

1 reference

16 October 2017

Takashi Komeno

2

1 reference

16 October 2017

Hiroshi Nishikawa

3

1 reference

16 October 2017

Atsushi Yoshida

4

1 reference

16 October 2017

Kazumi Takahashi

5

1 reference

16 October 2017

Nobuhiko Nomura

6

1 reference

16 October 2017

Yousuke Furuta

7

1 reference

16 October 2017

language of work or name

English

0 references

publication date

5 August 2013

1 reference

Antimicrobial Agents and Chemotherapy

16 October 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 October 2017

57

1 reference

16 October 2017

11

1 reference

16 October 2017

5202-5208

1 reference

T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

T-705 (favipiravir) inhibition of arenavirus replication in cell culture

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

The war against influenza: discovery and development of sialidase inhibitors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Mechanism of action of T-705 against influenza virus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Ribavirin's antiviral mechanism of action: lethal mutagenesis?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

In vitro and in vivo activities of anti-influenza virus compound T-705.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Proofreading function associated with the RNA-dependent RNA polymerase from influenza virus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

In vitro and in vivo activities of T-705 and oseltamivir against influenza virus

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

Characterization of influenza virus RNA complete transcripts

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811313

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23917318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23917318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00649-13

1 reference

16 October 2017

1 reference

16 October 2017

1 reference